135 related articles for article (PubMed ID: 15026741)
1. [The cost of Mohs micrographic surgery for basal cell carcinoma. The Ambroise Paré hospital's experience (Boulogne, France)].
Sznajder M; Chaussade V; Zimmermann U; Sei JF; Bendersky N; Franc B; Saiag P
Ann Dermatol Venereol; 2004 Feb; 131(2):150-6. PubMed ID: 15026741
[TBL] [Abstract][Full Text] [Related]
2. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
3. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
4. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
8. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
[TBL] [Abstract][Full Text] [Related]
9. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
Lear W; Mittmann N; Barnes E; Breen D; Murray C
J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
[TBL] [Abstract][Full Text] [Related]
10. Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance.
Sebaratnam DF; Choy B; Lee M; Paver R; Fernández Peñas P
Dermatol Surg; 2016 May; 42(5):633-8. PubMed ID: 27110895
[TBL] [Abstract][Full Text] [Related]
11. Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis.
Wu X; Elkin EB; Jason Chen CS; Marghoob A
J Am Acad Dermatol; 2015 Nov; 73(5):791-8. PubMed ID: 26341142
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.
Vanaclocha F; Daudén E; Badía X; Guillén C; Conejo-Mir JS; Sainz de Los Terreros M; Hamel L; Llorens MA;
Br J Dermatol; 2007 Apr; 156(4):769-71. PubMed ID: 17263811
[No Abstract] [Full Text] [Related]
13. Surgical decision making for basal-cell carcinoma of the face.
Feldman S; Pearce DJ; Williford PM
Lancet Oncol; 2008 Dec; 9(12):1119-20. PubMed ID: 19038758
[No Abstract] [Full Text] [Related]
14. [Therapeutic modalities and economic assessment in the treatment of superficial basal cell carcinomas and multiple actinic keratoses by French dermatologists].
Bernard P; Dupuy A; Brun P; Sasko A; Duru G; Nicoloyannis N; Decuypere L; Grob JJ
Ann Dermatol Venereol; 2007; 134(6-7):527-33. PubMed ID: 17657178
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous micrographic surgery: Mohs procedure.
Miller PK; Roenigk RK; Brodland DG; Randle HW
Mayo Clin Proc; 1992 Oct; 67(10):971-80. PubMed ID: 1434858
[TBL] [Abstract][Full Text] [Related]
16. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
[TBL] [Abstract][Full Text] [Related]
17. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis: Mohs micrographic surgery.
Ravitskiy L; Brodland DG; Zitelli JA
Dermatol Surg; 2012 Apr; 38(4):585-94. PubMed ID: 22443180
[TBL] [Abstract][Full Text] [Related]
19. Utility of dermoscopy for demarcation of surgical margins in Mohs micrographic surgery.
Suzuki HS; Serafini SZ; Sato MS
An Bras Dermatol; 2014; 89(1):38-43. PubMed ID: 24626646
[TBL] [Abstract][Full Text] [Related]
20. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
